As of 2024-12-12, the Relative Valuation of AroCell AB (publ) (AROC.ST) is (4.40) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.39 SEK, the upside of AroCell AB (publ) based on Relative Valuation is -1217.1%.
The range of the Relative Valuation is (4.83) - (5.90) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 35.6x | 24.1x |
| Forward P/E multiples | 15.6x - 26.9x | 16.0x |
| Fair Price | (4.83) - (5.90) | (4.40) |
| Upside | -1325.8% - -1596.6% | -1217.1% |
| Date | P/E |
| 2024-12-09 | -1.91 |
| 2024-12-06 | -2.10 |
| 2024-12-05 | -2.10 |
| 2024-12-04 | -1.83 |
| 2024-12-03 | -1.90 |
| 2024-12-02 | -1.73 |
| 2024-11-29 | -1.80 |
| 2024-11-28 | -1.84 |
| 2024-11-27 | -1.94 |
| 2024-11-26 | -1.87 |
| 2024-11-25 | -1.84 |
| 2024-11-22 | -1.85 |
| 2024-11-21 | -2.01 |
| 2024-11-20 | -1.88 |
| 2024-11-19 | -1.90 |
| 2024-11-18 | -1.97 |
| 2024-11-15 | -2.01 |
| 2024-11-14 | -2.03 |
| 2024-11-13 | -1.97 |
| 2024-11-12 | -2.04 |
| 2024-11-11 | -2.07 |
| 2024-11-08 | -2.23 |
| 2024-11-07 | -2.26 |
| 2024-11-06 | -2.30 |
| 2024-11-05 | -2.30 |
| 2024-11-04 | -2.27 |
| 2024-11-01 | -2.28 |
| 2024-10-31 | -2.27 |
| 2024-10-30 | -2.28 |
| 2024-10-29 | -2.32 |
| 2024-10-28 | -2.32 |
| 2024-10-25 | -2.28 |
| 2024-10-24 | -2.23 |
| 2024-10-23 | -2.30 |
| 2024-10-22 | -2.28 |
| 2024-10-21 | -2.30 |
| 2024-10-18 | -2.27 |
| 2024-10-17 | -2.30 |
| 2024-10-16 | -2.30 |
| 2024-10-15 | -2.37 |
| 2024-10-14 | -2.37 |
| 2024-10-11 | -2.35 |
| 2024-10-10 | -2.30 |
| 2024-10-09 | -2.37 |
| 2024-10-08 | -2.39 |
| 2024-10-07 | -2.41 |
| 2024-10-04 | -2.37 |
| 2024-10-03 | -2.41 |
| 2024-10-02 | -2.39 |
| 2024-10-01 | -2.35 |